Join us for a practical round table discussion addressing the ever-present, ever challenging topic of funding for life sciences R&D companies. 

Speakers and guests will have the opportunity to review the current climate, look at what's available, from who and who for. Speakers will also share insight into current and predicted future market trends and challenges, and consider how we compare to other international markets.  

Finally, we will discuss if our funding landscape is holding back innovation and what will it take to help support the UK in becoming the science and technology superpower of the future.

Programme:

08.30 Guest arrival, breakfast and networking

09.00 Welcome by Shawn Manning, Managing Director of Akesios Associates​ and Chair of OBN's Investment & Tax Advisory Group

Followed by two x 10-minute introductory keynotes from Simon Goldman, Partner​ AlbionVC​ (second speaker TBA) 

09.30 Round table discussion between all guests, Chaired by Stuart Rose, CEO of OBN​

10.30 Event close

Event format: OBN's round table C-Suite Discussions are designed exclusively for senior leaders (C-Suite or equivalent) from life sciences organisations, whether R&D or those involved in providing critical support services to the industry. The purpose of these events is to generate some interesting, useful, high-level and boundary pushing discussion and debate, that creates some practical thought-leadership output.

Please note that places are limited and will be offered on an approval only basis. Complimentary tickets available for OBN Members & Academics, non-OBN Member tickets available at £50.00 plus VAT.

This event is kindly hosted by The Oxford Science Park in the Thames Room of the Sadler Building